BioServices News
-
Astellas to have new facility at Takahagi Technology Center
BioServices | News | By BioSpectrum Bureau | 0 Comment | 28 Aug, 2012
Singapore: Astellas Pharma is constructing a new building at the Takahagi Technology Center in Japan. The building, whic...Read more
-
BSA-CMR Survey: Oncology is the top therapeutic focus area for CROs in APAC
BioServices | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Jay Dixon is PPD's quality, compliance senior VP
BioServices | News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2013
Singapore: Pharmaceutical Product Development (PPD) has appointed Mr Jay Dixon as senior vice president, global quality ...Read more
-
INC Research expands in Korea to meet local demand
BioServices | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2012
Singapore: INC Research, a therapeutically focused clinical research organization (CRO) with a trusted process for deli...Read more
-
Dr Rajput: Enjoy challenges to overcome them
BioServices | Influencers | By BioSpectrum Bureau | 0 Comment | 18 Jan, 2013
Dr Anuradha Rajput, managing director, Icon Central Laboratories, India, has been working with the company since the pas...Read more
-
BSA-CMR Survey: India, China lead in APAC CRO sector
BioServices | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
PPD gets Brazilian accreditation
BioServices | News | By BioSpectrum Bureau | 0 Comment | 22 Mar, 2013
Singapore: Pharmaceutical Product Development's (PPD) bioanalytical operation has been certified by Brazil's Agencia Nac...Read more
-
Quintiles begins trading on NYSE under 'Q' symbol
BioServices | News | By BioSpectrum Bureau | 0 Comment | 10 May, 2013
Singapore: Quintiles has made the pricing of its initial public offering (IPO) of 23,684,210 shares of its common stock ...Read more
-
iMedX appoints Mr Christopher Foley as new CEO
BioServices | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: US-based iMedX, a provider of healthcare clinical documentation solutions, has appointed Mr Christopher Foley...Read more
-
INC Research implements CRO accreditation program
BioServices | News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2013
Singapore: INC Research, a therapeutically focused global clinical research organization (CRO), has implemented Clinical...Read more
-
Inogent Lab gets Japan regulatory body approval
BioServices | Regulatory | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2012
Hyderabad: Inogent Laboratories, a GVK BIO associate company, has received approval from the the Japanese regulator for ...Read more
-
Boehringer, Apexigen collaborate for cancer mAbs
BioServices | News | By BioSpectrum Bureau | 0 Comment | 06 Dec, 2012
Singapore: Boehringer Ingelheim, a global leader in the field of biopharmaceuticals manufacturing, and Apexigen, an emer...Read more
-
China marches ahead with regulatory approvals
BioServices | News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012
After five years of amendments and two rounds of public consultations, the State Food and Drug Administration (SFDA) iss...Read more
-
High burden of rotavirus in Bangladesh
BioServices | News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2014
Singapore: Findings from hospital-based surveillance conducted by The International Centre for Diarrhoeal Disease Resear...Read more
-
Fibrotech's fibrosis drugs secures NA patents
BioServices | News | By BioSpectrum Bureau | 0 Comment | 03 Mar, 2014
Singapore: Fibrotech Therapeutics, based in Melbourne has secured composition of matter patents in each jurisdiction rel...Read more
-
Aussie firm Mayne to acquire Metrics
BioServices | News | By BioSpectrum Bureau | 0 Comment | 08 Oct, 2012
Singapore: Mayne Pharma has entered into a binding agreement to acquire Metrics, a privately-owned, US-based provider of...Read more
-
Kinex, Hanmi enroll patients for cancer trial
BioServices | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2013
Singapore: Kinex Pharmaceuticals and Hanmi Pharmaceutical announced today that the first patient has been enrolled in Ha...Read more
-
SeerPharma explores markets in India, China
BioServices | Influencers | By BioSpectrum Bureau | 0 Comment | 24 May, 2012
Australia-based SeerPharma, which offers international quality management and compliance experience, and advice to suppo...Read more
